‘Kenya’s guinea pig’: How twice-a-year anti-HIV jab changed brave man’s life
Samson Mutua, the first Kenyan to receive the twice-a-year anti-HIV injection Lenacapavir, is working to combat the stigma surrounding the treatment. Despite facing public abuse, he now promotes the injection as a community health advocate.
Why it matters
The story highlights the intersection of medical innovation and social stigma, emphasizing the need for public education alongside the rollout of new health technologies.
Samson Mutua, 27, was the first Kenyan to receive lenacapavir, a new injection that protects against HIV for six months with just two doses a year. Photo credit: WHO / Genna Print
The article focuses on a human interest story and public health challenges without taking a political stance.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in